Berry, C., Mangion, K., Sykes, R., Briscoe, M., Krysztofiak, T., & Peck, O. Type 2 myocardial infarction and myocardial injury: Eligibility for novel medical therapy to derisk clinical trials. BMJ Publishing Group.
Chicago Style (17th ed.) CitationBerry, Colin, Kenneth Mangion, Robert Sykes, Michael Briscoe, Thomas Krysztofiak, and Oliver Peck. Type 2 Myocardial Infarction and Myocardial Injury: Eligibility for Novel Medical Therapy to Derisk Clinical Trials. BMJ Publishing Group.
MLA (9th ed.) CitationBerry, Colin, et al. Type 2 Myocardial Infarction and Myocardial Injury: Eligibility for Novel Medical Therapy to Derisk Clinical Trials. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.